| Literature DB >> 33376112 |
Yelena Drexler1, Judith Molina2, Alla Mitrofanova2, Alessia Fornoni2, Sandra Merscher1.
Abstract
In the past few decades, sphingolipids and sphingolipid metabolites have gained attention because of their essential role in the pathogenesis and progression of kidney diseases. Studies in models of experimental and clinical nephropathies have described accumulation of sphingolipids and sphingolipid metabolites, and it has become clear that the intracellular sphingolipid composition of renal cells is an important determinant of renal function. Proper function of the glomerular filtration barrier depends heavily on the integrity of lipid rafts, which include sphingolipids as key components. In addition to contributing to the structural integrity of membranes, sphingolipid metabolites, such as sphingosine-1-phosphate (S1P), play important roles as second messengers regulating biologic processes, such as cell growth, differentiation, migration, and apoptosis. This review will focus on the role of S1P in renal cells and how aberrant extracellular and intracellular S1P signaling contributes to the pathogenesis and progression of kidney diseases.Entities:
Keywords: ceramide; kidney disease; sphingolipid metabolism; sphingolipids; sphingosine-1-phosphate
Mesh:
Substances:
Year: 2020 PMID: 33376112 PMCID: PMC7894665 DOI: 10.1681/ASN.2020050697
Source DB: PubMed Journal: J Am Soc Nephrol ISSN: 1046-6673 Impact factor: 14.978